key: cord-0832145-u2c5xfos
authors: Sartor, Gino; Riccio, Marco Del; Poz, Irene Dal; Bonanni, Paolo; Bonaccorsi, Guglielmo
title: COVID-19 in Italy: considerations on official data
date: 2020-06-20
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.06.060
sha: cddf9aa2425d7e50bdf7378547c01673e421c153
doc_id: 832145
cord_uid: u2c5xfos

Abstract COVID-19 represents a major public health issue in Italy; estimating the size of the outbreak could direct public health policies and inform us on the extent of the reorganization needed in the healthcare system, on the efficacy of quarantine measures and eventually on the achievement of herd immunity. In order to chart the real extent of COVID-19 infection in Italy, official data need to be interpreted considering various aspects such the “suspected-case” definition, that changed during the past months, the management of asymptomatic and untested symptomatic cases, the deaths reporting system and short-term fluctuations. All these aspects should be taken into consideration when reflecting about the meaning of the official COVID-19 figures in Italy. Regionalization of the healthcare system and fragmentation of data represent real challenges in the management of the COVID-19 outbreak in Italy. Authors’ opinion is that a transparent and accurate reporting could guide policymaking and help reorganize health services.

COVID-19 represents a major public health issue. March 11 th the World Health Organization (WHO) officially declared Covid-19 outbreak a pandemic [1] . This virus can easily spread [2, 3] and can lead to asymptomatic cases [4, 5] , mild syndromes [6, 7] as well as severe manifestations, requiring hospitalization and Intensive Care Unit (ICU) [7] . Italy is among world's worst-hit countries [8] and the first among Western countries to order a national lockdown.

Accurate estimates of the size of the outbreak could influence public health policies. They could inform Covid-19 research on the necessary reorganization of healthcare system and on J o u r n a l P r e -p r o o f the efficacy of quarantine measures. Finally, accurate estimates could improve our understanding on how close we are to the acquisition of herd immunity.

National bulletins provide us with official data on analyzed swabs, confirmed cumulative cases, home isolation cases, hospitalized cases, ICU cases, and deaths [8] . However, Russel et al. estimate that Italy is one of the countries with the highest percentage of unreported cases of COVID-19 [9] . The regionalization of data flow represents another challenge. Data is communicated dailyin an aggregate fashion -by every region to the national authorities but there is no standardized collection of data. In parallel, public health services upload individual data on a surveillance system online platform. While the first data flow is region-dependent but has the advantage of being daily updated, the second is more standardized but notifications refer to cases diagnosed on previous days. In this paper, we will refer to the first data flow, which has extensively been used by scientists and media to analyze the evolution of the pandemic. Regarding this data flow, the lack of uniformity among Italian regional data raised the unconvincing hypothesis of differently virulent SARS-CoV-2 types. Thus, to track the real extent of COVID-19 infection in Italy, it needs to be interpreted according to the following points.

At the beginning of the epidemic, the definition of "suspected case" to be tested for SARS-CoV-2 was based on symptoms (fever, cough and flu-like symptoms) and history of travelling or residence in China or Italian "red areas". This testing policy explains why the regions of Lombardy and Veneto initially collected more samples. The definition was later revised as a person with acute respiratory infection associated with either a history of travel or residence in an area reporting local transmission of COVID-19, close contact with a confirmed or probable COVID-19 case or requiring hospitalization [10] . Nonetheless, Veneto decided to extend J o u r n a l P r e -p r o o f testing to asymptomatic people with a close contact with confirmed cases or asymptomatic people in red areas.

Therefore, the proportion of population tested varies among regions. The percentage of samples over the total population ranges from 0.92% in Campania to 5.46% in Veneto (data updated April 21 st ) [8] .

Taking the proportion of tested population into consideration helps us interpret official data.

For example, Veneto (the region that tested the most) and Piedmont have recorded similar numbers of confirmed cases until mid-April. The number of deaths, number of ICU and hospitalized patients, however, was much higher in the latter. This suggests that a vast number of infections went undetected in Piedmont. Even though most of these undetected cases probably presented mild or moderate symptoms, some critical patients might have died without a confirmed diagnosis.

Short-term fluctuations might compromise the reliability of daily data. These fluctuations are due to laboratory delayse.g. results delays due to laboratory saturationor calendar effects.

The number of swabs tends to drop on weekends, and thus we notice a weekly pattern in the time series of the number of swabs and positive cases ( Figure 1) . Techniques, such as moving averages, should be considered to account for this variability. 

The number of asymptomatic and untested symptomatic subjects is important to track the size of the outbreak. In literature there remains a high level of uncertainty in the estimates of the percentage of asymptomatic carriers [11] . We hypothesize that untested symptomatic subjects develop mostly mild or moderate syndromes. Tabata et al., for example, found that 43 out of 104 patients were mildly symptomatic on the "Diamond Princess" [12] .

Reasons for underdiagnosis of asymptomatic and mildly/moderately symptomatic patients may be: a) political and healthcare choices; b) geographic proximity to "red areas" [13] ; c) strength and flexibility of public health services and primary care services; d) availability of swabs and/or laboratories to analyze samples [14] .

It is worth remarking that the number of ICU patients is given as daily prevalence data, while the total number of positive cases and deaths is cumulative. We should consider that total number of ICU cases may reflect the saturation of ICU capacity and not the total need for ICU beds [15] . Moreover, some of dead and healed subjects must have previously been taken care of in ICU. Zhou et al. found that out of 54 deaths in a hospital setting, 42 had been cured in ICU, i.e. 77.7%) while 12 were never admitted to ICU -22.3%, probably because of old age, comorbidities or lack of ICU beds [16] . However, deaths do not always occur in hospital wards or ICUs. Particularly in those areas where deaths and healings now significantly outnumber prevalent ICU cases, the percentage of subjects who would need intensive treatment over the total of infected cases is underestimated.

The Italian National Institute of Statistics (ISTAT) adopted the WHO ICD-10 code of 'U07.1 COVID-19, virus identified' and 'U07.2 COVID-19, virus not identified' to code deaths from COVID-19 as confirmed or not by laboratory testing. Nonetheless, we expect underreporting and misclassification.

In Nembro (province of Bergamo), one of the most affected municipalities, the number of expected deaths in the first three months of 2020 under normal conditions was 35. 158 deaths were instead registered by municipal offices. The number of deaths officially attributed to COVID-19 is 31. It is reasonable to expect that the deaths in excess occurred at home or in care homes [17] .

However, we cannot exclude some cases of misclassification due to ascertainment bias, i.e., coding deaths from severe respiratory syndrome with 'U07.2 COVID-19, virus not identified'. to 3.6% [20] . As noted by Onder et al., the proportion of positive cases over total samples positively correlates with the CFR [21] .

Regionalization of the healthcare system and fragmentation of data represent challenges in the management of the COVID-19 outbreak in Italy. The lack of a strong centralized response to the emergency resulted in different regional policies, especially in terms of testing strategies. Table 1 : Regional population, number of samples, percentage of samples over population, cumulative number of reported cases, percentage of cases over population, percentage of collected samples over cases, hospitalization ratio and hospital vs home care ratio. Hospitalization ratio is the percentage of hospitalized cases over total cases (this value is the mean of the ratios calculated daily since the beginning of the pandemic). Hospital vs Home Care ratio is the percentage of hospitalized cases over cases managed at home (this value represents the mean of the ratios calculated daily since the beginning of the pandemic) [22] .

J o u r n a l P r e -p r o o f

Coronavirus disease (COVID-2019) situation reports. Geneva: WHO

Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

of Novel Coronavirus-Infected Pneumonia

Estimating the asymptomatic proportion of coronavirus disease 2019 ( COVID-19 ) cases on board the Diamond Princess cruise ship

Clinical Characteristics of Coronavirus Disease 2019 in China

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

Chinese Center for Disease Control and Prevention

Coronavirus Disease (COVID-19) Situation Report in Italy. Rome: Ministry of Health, Italy

Using a delayadjusted case fatality ratio to estimate under-reporting. C Repos

Italian Ministry of Health

COVID-19: What proportion are asymptomatic? Oxford: CEBM

The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan. medRxiv

Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy

As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation

Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

The real death toll for Covid-19 is at least 4 times the official numbers. Rome: CdS

Estimating Risk for Death from 2019 Novel Coronavirus Disease, China

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease

Estimates of the severity of coronavirus disease 2019: a model-based analysis

Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy

Analisi dei modelli organizzativi di risposta al COVID-19: focus su Lombardia